Cinctive Capital Management’s Exact Sciences EXAS Stock Holding History

Cinctive Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,000	Closed	-$650K	–	442
2022 Q3	$650K	Sell	20,000 -50,000	-71%	-$2.06M	0.03%	371
2022 Q2	$2.76M	Buy	70,000 +40,000	+133%	+$2.14M	0.12%	269
2022 Q1	$2.1M	Hold	30,000	–	–	0.08%	323
2021 Q4	$2.33M	Buy	30,000 +10,000	+50%	+$883K	0.1%	282
2021 Q3	$1.91M	Buy	+20,000	New	+$2.11M	0.09%	302

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cinctive Capital Management's EXAS Position: Q1 2026 in Review

Cinctive Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 330,000 shares — an estimated $33.5M sold.

Cinctive Capital Management first reported a position in EXAS in Q3 2020 and held it in 10 quarters. The position peaked at $33.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Cinctive Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Cinctive Capital Management sold 330,000 Exact Sciences shares in Q1 2026, an estimated $33.5M.
Cinctive Capital Management first reported a position in Exact Sciences in Q3 2020 and held it in 10 quarters.
Cinctive Capital Management's Exact Sciences position peaked at $33.5M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.